Challenges Budgeting of a clinical trial project requires an assessment of all possible risks and a clear understanding of the project plan. It’s almost impossible to estimate the true effort required to complete a project without analysis of potential risks, which in turn determines the workload for the project and thus the final budget. Despite […]
Research Professionals, Executive Committee Member. By joining ACROSS and being part of the Innovation and Technology Board, Research Professionals will have the opportunity to create value by validating its ideas on a global level. Unique selling points (USPs) are unique characteristics of a product or brand identified by the marketer as the one on which […]
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ As a matter of fact this is an updated version of my old post. An Up-to-dated Repost… Seventy years ago, when TV became widespread, pundits said it would replace all the other arts and media: books, newspapers, radio, theater, cinema, all of it. […]
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ Let’s take a break from risks and take a look at another promising trend which is also in the area of Synergy’s particular interest, blockchain technology. Let’s talk about tokens… Firstly, to make sure we’re on the same page, I’d like to explain […]
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ I’m a system engineer by my first higher education. The diploma says “System Engineer in Design and Evaluation of Combat Aircraft”. For five years after graduation from university I was involved in top secret work on the optimization of all Russian combat aircrafts. […]
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ The Ministry of Health of the Russian Federation approved the initiation of 184 new clinical trials of all types in Russia during Q3 2018, including local clinical trials (LCT) and bioequivalence (BE) studies with an overall year on year growth rate of 17% […]
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ I’m pleased to introduce to you the European edition of our Orange Paper. Accrording to CT.GOV data, 6,396 new clinical trials of all types were started suring Q3 2018 worldwide. This comprises local and bioequivalence studies. There were 2,076 studies approved in USA […]
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ I’m pleased to introduce to you the new edition of our Orange Paper analysing clinical trials in the USA during Q3 2018. Meet the new USA member of SRG’s Orange Paper family! Worldwide Trials Up 19% According to ClinicalTrials.gov, 6,396 new clinical trials […]
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ The sun rises soon after the rooster crows. What is the rooster in this case? Is the rooster a source of risk or just a key risk indicator? Is there a risk that sun will not rise, once the rooster doesn’t crow? With […]
Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ Our modern “Risk Assessment” is very similar to that of the ancient art of divination. Technology is different, but objectives are the same. We try to predict the future, identify and evaluate the potential hazards and understand how to avoid them. Instead of […]
Whether you are planning an entire clinical development plan, or perhaps just planning a single study, why not contact us for a free, no obligation consultation. With our expert team of clinical developers on hand, we can provide you with the best options to help you with the success of your project(s). Please complete the information below and we will contact you within one working day to schedule your consultation. We look forward to assisting you!
We will contact you within 24 hours.